Paradoxically, a recent study demonstrated that TIGIT was expressed on 53% and 28% of CD8+ and CD4+ T cells, respectively, within PDAC tumor-infiltrating lymphocyte populations 38. The gene discussed is CD8A; the disease is neoplasm.